TURN THERAPEUTICS INC (TTRX) Forecast, Price Target & Analyst Ratings
NASDAQ:TTRX • US90021W1053
3.38 USD
-0.04 (-1.02%)
At close: Mar 5, 2026
3.3601 USD
-0.02 (-0.59%)
After Hours: 3/5/2026, 8:24:29 PM
View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for TURN THERAPEUTICS INC (TTRX).
Forecast Snapshot
Consensus Price Target
$7.22
+ 113.51% Upside
Next Earnings Forecast
Release DateN/A
PeriodQ4 / 2025
EPS Estimate-$0.04
Revenue Estimate
ChartMill Buy Consensus
82.50%
Weighted Analyst Rating Score
Price Target Details & History
Consensus Price Target and Range
Mean target
$7.22
Upside
+ 113.51%
From current price of $3.38 to mean target of $7.22, Based on 8 analyst forecasts
Low
$6.21
Median
$7.22
High
$8.40
Price Target Revisions
1 Month
N/A
3 Months
N/A
Price Target Summary
8 analysts have analysed TTRX and the average price target is 7.22 USD. This implies a price increase of 113.51% is expected in the next year compared to the current price of 3.38.
Analyst Ratings & History
Current Analyst Ratings
Analyst Ratings History
Analyst Ratings Consensus
ChartMill Buy Consensus
82.50%
TTRX was analyzed by 8 analysts. The buy percentage consensus is at 83. So analysts seem to be very confident about TTRX.
TTRX was analyzed by 8 analysts. More opinions would make the average more meaningful.
Recent Upgrades & Downgrades
| Date | Firm | Action | From → To |
|---|---|---|---|
| 2026-01-20 | D. Boral Capital | Maintains | Buy -> Buy |
| 2025-12-29 | D. Boral Capital | Initiate | Buy |
Next Earnings Forecast Details
Next Earnings Details
Release DateN/A
PeriodQ4 / 2025
EPS Estimate-$0.04
Revenue EstimateN/A
Revenue Q2QN/A
EPS Q2QN/A
Number of Analysts3
Next Earnings Revisions
Revenue (1 Month)
N/A
Revenue (3 Months)
N/A
EPS (1 Month)
N/A
EPS (3 Months)
N/A
Next Earnings Summary
Full Analyst Estimates
Yearly Earnings Per Share (EPS), Revenue, EBIT, EBITDA and Operating Margin Analyst Estimates
| 2022 | 2023 | 2025 | 2026 | 2027 | ||
|---|---|---|---|---|---|---|
| Revenue YoY % growth | N/A | N/A | N/A -98.73% | |||
| EBITDA YoY % growth | N/A | -2.254M | N/A | N/A | N/A | |
| EBIT YoY % growth | -4.21M | -2.308M 45.17% | N/A | N/A -1.99% | N/A -81.91% | |
| Operating Margin | N/A | N/A | N/A | N/A | N/A | |
| EPS YoY % growth | N/A | N/A | N/A | N/A 24.14% | N/A -131.82% |
Quarterly Earnings Per Share (EPS), Revenue, EBIT and EBITDA Analyst Estimates
| Q4 / 25 | Q1 / 26 | |
|---|---|---|
| EPS Q2Q % growth | -0.04 | -0.03 |
| Revenue Q2Q % growth | N/A | N/A |
| EBITDA Q2Q % growth | N/A | N/A |
| EBIT Q2Q % growth | N/A | -905.76K |
Yearly Earnings Per Share (EPS) and Revenue Trends vs Historical Data
Long Term Forward Growth Forecast Summary
Long Term EPS Growth (CAGR)
EPS Next 3 Year
N/A
EPS Next 5 Year
N/A
Long Term Revenue Growth (CAGR)
Revenue Next 3 Year
N/A
Revenue Next 5 Year
N/A
Long Term EBIT Growth (CAGR)
EBIT Next 3 Year
N/A
EBIT Next 5 Year
N/A
TURN THERAPEUTICS INC / TTRX Forecast FAQ
What is the price target for TTRX stock?
8 analysts have analysed TTRX and the average price target is 7.22 USD. This implies a price increase of 113.51% is expected in the next year compared to the current price of 3.38.
Can you provide the analyst count for TURN THERAPEUTICS INC stock?
The number of analysts covering TURN THERAPEUTICS INC (TTRX) is 8.